Table 1 Risk factors for venous thromboembolism[2],[16]-[19]
From: Treatment options for venous thromboembolism: lessons learnt from clinical trials
Genetic | |
Factor V Leiden | Prothrombin G20210A |
Antithrombin deficiency | Prothrombin C deficiency |
Family history of venous thromboembolism | Prothrombin S deficiency |
Hyperhomocysteinaemia | Sickle cell trait |
Acquired, non-transient | |
Increased age | Spinal cord injury |
Obesity | Prior venous thromboembolism |
Chronic medical illness | Central venous lines |
Cancer | Transvenous pacemaker |
Antiphospholipid antibodies | Neurological disease with leg paresis |
Heparin-induced thrombocytopenia | |
Myeloproliferative disorders | |
Acquired, transient | |
Surgery | Medications, including |
Trauma | hormonal contraceptives, |
Fractures | hormone therapy, |
Immobilization | chemotherapy drugs, |
Pregnancy and childbirth | epoietin-alpha and |
Red blood cell transfusion | darbepoietin-alpha |